Даниэль Шуваль

Должность: Профессор старший врач отделения гепатологии
Принимает: только взрослых



Старший врач отделения гепатологии. Выпускник Еврейского университета в Иерусалиме.

Проходил стажировку в больницах Англии и США, включая центр по изучению печени при больнице имени Альберта Энштейна в Нью-Йорке и медицинский центр Massachusetts General в Бостоне.

Профессор Шуваль  диагносцирует и проводит лечение заболеваний печени, включая вирусные и аутоимунные заболевания печени, болезни кровеносных сосудов печени, болезни печени при беременности, повреждение печени от лекарственных препаратов, злокачественные новообразования печени.

В рамках научной работы професор разрабатывает вакцины и лекарственные препараты для лечения инфекционных воспалений печени и первичного рака печени. Профессор так же является приглашенным профессором в университете Гарвард, США, Альберт Энштейн в США и в Парижском университете.

Является консультантом всемирной организации здравоохранения и министерства здравоохранения Израиля

Автор более 200 научных публикаций.

Научные публикации

Early Antibiotics Usage During Infancy is Associated With High Risk of Celiac Disease Autoimmunity: A Population-based Study
The Viral Hepatitis Prevention Board (VHPB) supports the continued recommendation for universal hepatitis B vaccination of all newborns within 24 hours of birth
Correction: Population Pharmacokinetics Analysis of Infliximab in up to 10‑Year‑Old Patients with Paediatric Inflammatory Bowel Disease: Label‑Recommended Dose Fails to Achieve Therapeutic Target Concentration
Chronic nonbacterial osteomyelitis associated with pediatric inflammatory bowel disease: A multicenter retrospective study from the Paediatric IBD Porto Group of ESPGHAN
Population Pharmacokinetics Analysis of Infliximab in up to 10-Year-Old Patients with Paediatric Inflammatory Bowel Disease: Label-Recommended Dose Fails to Achieve Therapeutic Target Concentration
Anti-Saccharomyces cerevisiae antibodies positivity is not linked to antitumor necrosis factor-α durability in pediatric Crohn's disease patients: A single-center study
RELA Haploinsufficiency Manifesting as an Atypical Phenotype of Crohn's Disease
Management of paediatric ulcerative colitis, part 1: Ambulatory care-An updated evidence-based consensus guideline from the European Society of Paediatric Gastroenterology, Hepatology and Nutrition and the European Crohn's and Colitis Organisation
Gaps between European Crohn's and Colitis Organisation quality standards of care and the real world on diagnosis and monitoring inflammatory bowel disease across Europe: results from the E-QUALITY survey
Whole Food Diet Induces Remission in Children and Young Adults With Mild to Moderate Crohn's Disease and Is More Tolerable Than Exclusive Enteral Nutrition: A Randomized Controlled Trial
Management of paediatric ulcerative colitis, part 2: Acute severe colitis-An updated evidence-based consensus guideline from the European Society of Paediatric Gastroenterology, Hepatology and Nutrition and the European Crohn's and Colitis Organization
Gaps between European Crohn's Colitis Organisation quality standards of care and the real world on structure of IBD units across Europe: results from E-QUALITY survey
Safety and Effectiveness of QingDai (Indigo naturalis) in Children With Mild-to-Moderate Ulcerative Colitis: A Short-Term 6-Week Open-Label Trial
Tumor necrosis factor α inhibitor-induced alopecia in pediatric patients: a cohort of 20 patients and review of the literature
The Genetic Architecture of Congenital Diarrhea and Enteropathy
Immune dysregulation in glycogen storage disease 1b extends beyond neutropenia
Long-term laboratory follow-up is essential in pediatric patients with celiac
Upadacitinib for Induction of Remission in Paediatric Crohn's Disease: An International Multicentre Retrospective Study
Maintenance-phase serum anti-TNF levels are not associated with mucosal healing in pediatric Crohn's disease
Metagenome-informed metaproteomics of the human gut microbiome, host, and dietary exposome uncovers signatures of health and inflammatory bowel disease
Effectiveness and Safety of Adalimumab in Patients With Very Early-Onset Inflammatory Bowel Disease: A Retrospective Study on Behalf of the Porto Inflammatory Bowel Disease Working Group of European Society for Pediatric Gastroenterology Hepatology and Nutrition
Crohn's Disease Manifestation as An Intranasal Space-Occupying Lesion
Long-term outcome of pediatric acute severe colitis: A prospective 5-year follow-up of the PRASCO trial
Upadacitinib for Induction of Remission in Pediatric Ulcerative Colitis: An International Multicenter Study
Serological Markers as Predictors of Anti-TNF Response in Children with Crohn's Disease
Response to FDA draft guidance on pediatric IBD drug approval trials: A consensus statement from the IBD Porto Group
The Nancy Histopathological Index has limited value in predicting clinical outcomes in newly diagnosed pediatric patients with ulcerative colitis
Paradoxical psoriasiform skin eruption in paediatric patients with inflammatory bowel disease treated with tumour necrosis factor-α inhibitors
Acquired tracheoesophageal fistula following rubber toy ingestion
A spatial expression atlas of the adult human proximal small intestine
Infantile and Very Early Onset Inflammatory Bowel Disease: A Multicenter Study
Clinical characteristics and outcomes of pediatric patients with autoimmune gastritis
Different infliximab induction dosing regimens do not affect remission rates up to 1 year in children with Crohn's disease
Sexual health in adolescents with inflammatory bowel disease - The paediatric gastroenterologists' point of view
Tofacitinib in Pediatric Ulcerative Colitis: A Retrospective Multicenter Experience
Familial Mediterranean fever in patients with inflammatory bowel diseases: a nationwide study from the epi-IIRN
STEP-CD study: ustekinumab use in paediatric Crohn's disease-a multicentre retrospective study from paediatric IBD Porto group of ESPGHAN
Longterm Outcome of Therapeutic Vaccination with a Third Generation Pre-S/S HBV Vaccine (PreHevbrioR) of Chronically HBV Infected Patients
A significant increase in anthropometric indices during long-term follow-up of pediatric patients with celiac disease, with no endocrine disorders
Mucosal Genes Encoding Clock, Inflammation and Their Mutual Regulators Are Disrupted in Pediatric Patients with Active Ulcerative Colitis
New-onset Blepharitis and Anti-TNF-Alpha Therapy in Patients with Crohn's Disease: A Case Series and Literature Review
Adherence to the Mediterranean Diet Is Associated with Decreased Fecal Calprotectin Levels in Children with Crohn's Disease in Clinical Remission under Biological Therapy
Adjusted estimate of the prevalence of hepatitis delta virus in 25 countries and territories
Autoimmune amelogenesis imperfecta in patients with APS-1 and coeliac disease
Precision medicine in monogenic inflammatory bowel disease: proposed mIBD REPORT standards
Hepatitis A virus infection
Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study
Thiopurines Maintenance Therapy in Children With Ulcerative Colitis: A Multicenter Retrospective Study
Clinical Features and Natural History of Paediatric Patients with Ulcerative Proctitis: A Multicentre Study from the Paediatric IBD Porto Group of ESPGHAN
A sound mind in a sound body: Stress-induced glucocorticoids exacerbate gut inflammation
Показать ещё 42 статьи Скрыть статьи
Остались вопросы?
Напишите нам и мы свяжемся с вами в течение ближайшего времени и ответим на все интересующие вопросы